Rad51 Degradation: Role in Oncolytic Virus—Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rad51 Degradation: Role in Oncolytic Virus—Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 109, Issue 3, Pages -
Publisher
Oxford University Press (OUP)
Online
2017-02-10
DOI
10.1093/jnci/djw229
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Food on the Pharmacokinetics of Olaparib after Oral Dosing of the Capsule Formulation in Patients with Advanced Solid Tumors
- (2015) Christian Rolfo et al. ADVANCES IN THERAPY
- Synthetic Lethality and Cancer Therapy: Lessons Learned from the Development of PARP Inhibitors
- (2015) Christopher J. Lord et al. Annual Review of Medicine
- The PARP1 inhibitor BMN 673 exhibits immunoregulatory effects in a Brca1 −/− murine model of ovarian cancer
- (2015) Jing Huang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Molecular Pathways: Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus Immunotherapy
- (2015) F. J. Kohlhapp et al. CLINICAL CANCER RESEARCH
- HSV-I and the cellular DNA damage response
- (2015) Samantha Smith et al. Future Virology
- Poly (ADP-Ribose) Polymerase Inhibitors: Recent Advances and Future Development
- (2015) Clare L. Scott et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting the DNA Damage Response in Cancer
- (2015) Mark J. O’Connor MOLECULAR CELL
- Genetic and Functional Diversity of Propagating Cells in Glioblastoma
- (2015) Sara G.M. Piccirillo et al. Stem Cell Reports
- Designing herpes viruses as oncolytics
- (2015) Cole Peters et al. Molecular Therapy-Oncolytics
- Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells
- (2014) Mario L. Suvà et al. CELL
- The Use of Olaparib (AZD2281) Potentiates SN-38 Cytotoxicity in Colon Cancer Cells by Indirect Inhibition of Rad51-Mediated Repair of DNA Double-Strand Breaks
- (2014) M. Tahara et al. MOLECULAR CANCER THERAPEUTICS
- PARP inhibitor olaparib increases the oncolytic activity of dl922-947 in in vitro and in vivo model of anaplastic thyroid carcinoma
- (2014) Carmela Passaro et al. Molecular Oncology
- Targeting Poly(ADP-Ribose) Polymerase and the c-Myb-Regulated DNA Damage Response Pathway in Castration-Resistant Prostate Cancer
- (2014) L. Li et al. Science Signaling
- Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches
- (2014) Felix Dietlein et al. TRENDS IN GENETICS
- Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy
- (2014) Jianfang Ning et al. Frontiers in Microbiology
- Immunovirotherapy for glioblastoma
- (2013) Jianfang Ning et al. CELL CYCLE
- Roles of Chk1 in cell biology and cancer therapy
- (2013) Youwei Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy
- (2013) Kaoru Tamura et al. JOURNAL OF NEUROSURGERY
- DNA Damage Sensing by the ATM and ATR Kinases
- (2013) A. Marechal et al. Cold Spring Harbor Perspectives in Biology
- An Aberrant Transcription Factor Network Essential for Wnt Signaling and Stem Cell Maintenance in Glioblastoma
- (2013) Esther Rheinbay et al. Cell Reports
- Glioblastoma cancer stem cells – From concept to clinical application
- (2012) Barbara E. Stopschinski et al. CANCER LETTERS
- Regulation of alphaherpesvirus infections by the ICP0 family of proteins
- (2012) C. Boutell et al. JOURNAL OF GENERAL VIROLOGY
- Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein
- (2012) M. H. Orzalli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Novel Oncolytic Herpes Simplex Virus that Synergizes with Phosphoinositide 3-kinase/Akt Pathway Inhibitors to Target Glioblastoma Stem Cells
- (2011) R. Kanai et al. CLINICAL CANCER RESEARCH
- Glioblastoma survival in the United States before and during the temozolomide era
- (2011) Derek R. Johnson et al. JOURNAL OF NEURO-ONCOLOGY
- Oncolytic Virus-Mediated Manipulation of DNA Damage Responses: Synergy With Chemotherapy in Killing Glioblastoma Stem Cells
- (2011) Ryuichi Kanai et al. JNCI-Journal of the National Cancer Institute
- Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells
- (2011) H. Wakimoto et al. NEURO-ONCOLOGY
- Rad51 and BRCA2 - New Molecular Targets for Sensitizing Glioma Cells to Alkylating Anticancer Drugs
- (2011) Steve Quiros et al. PLoS One
- Human Glioblastoma-Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
- (2009) H. Wakimoto et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started